Tingting Zeng

Nov 27, 2023 | onlinelibrary.wiley.com | Shuyan Wang |Jing An |Xueru Hu |Tingting Zeng

INTRODUCTION Patients with small cell lung cancer (SCLC) have a very poor prognosis, particularly those at an advanced stage of disease.1, 2 The first-line treatment for small cell lung cancer is chemotherapy, but tumor cells are prone to rapidly transitioning from being chemotherapy sensitive to chemotherapy resistant.3-6 Current studies have reported that immunotherapies for the treatment of small cell lung cancer have shown promising results.7-11 Heterogeneity and the immune...